Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients

Analytical Biochemistry

Volumn 433, Issue 2, 2013, Pages 227-234

  Benesova, L ^a   Belsanova, B ^a   Suchanek, S ^b,c,d   Kopeckova, M ^a   Minarikova, P ^b,c,d   Lipska, L ^c,e   Levy, M ^c,e   Visokai, V ^c,e   Zavoral, M ^b,c,d   Minarik, M ^a  

^a Genomac Research Institute   (Czech Republic)

^b IPVZ   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d CENTRAL MILITARY HOSPITAL   (Czech Republic)

^e FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

Author keywords

BEAMing; Cancer; Capillary electrophoresis; cfDNA; COLD PCR; Digital PCR; Mutations

Indexed keywords

BLOOD; BLOOD VESSELS; CAPILLARY ELECTROPHORESIS; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; DISEASE CONTROL; DISEASES; DNA; EMULSIFICATION; TUMORS; ULTRASONIC APPLICATIONS;

BEAMING; CANCER; CFDNA; COLD-PCR; DIGITAL PCR; MUTATIONS;

POLYMERASE CHAIN REACTION;

ANTICOAGULANT AGENT; CELL FREE DNA; CHLOROFORM; DNA; DNA FRAGMENT; PHENOL; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CAPILLARY ELECTROPHORESIS; CENTRIFUGATION; CONSTANT DENATURANT CAPILLARY ELECTROPHORESIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; LYSOSOME; MUTATION; MUTATIONAL ANALYSIS; PHAGOLYSOSOME; PHAGOSOME; PRIORITY JOURNAL; PSEUDOPODIUM; REAL TIME POLYMERASE CHAIN REACTION; SINGLE MOLECULE SEQUENCING; TARGETED DEEP SEQUENCING; TEMPERATURE GRADIENT CAPILLARY ELECTROPHORESIS; TUMOR NECROSIS;

EID: 84871630944     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2012.06.018     Document Type: Review

References (96)

1. J.J. Ott, A. Ullrich, M. Mascarenhas, and G.A. Stevens Global cancer incidence and mortality caused by behavior and infection J. Public Health (Oxf.) 33 2011 223 233
2. R.E. Schoen, J.L. Weissfeld, J.M. Trauth, B.S. Ling, and M. Hayran A population-based community estimate of total colon examination: the impact on compliance with screening for colorectal cancer Am. J. Gastroenterol. 97 2002 446 451
3. E. Monnet, J. Faivre, L. Raymond, and I. Garau Influence of stage at diagnosis on survival differences for rectal cancer in three European populations Br. J. Cancer 81 1999 463 468
4. M. Chao, and P. Gibbs Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer J. Clin. Oncol. 27 2009 e279 e280
5. G. Low, L.M. Tho, E. Leen, E. Wiebe, S. Kakumanu, A.C. McDonald, and F.W. Poon The role of imaging in the pre-operative staging and post-operative follow-up of rectal cancer Surgeon 6 2008 222 231
6. T. Irvine, M. Scott, and C.I. Clark A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer Colorectal Dis. 9 2007 527 531
7. M.J. Goldstein, and E.P. Mitchell Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer Cancer Invest. 23 2005 338 351
8. P. Mandel, and P. Metais Les acides nucleiques du plasma sanguin chezl'homme C.R. Acad. Sci. Paris 142 1948 241 243
9. A. Bendich, T. Wilczok, and E. Borenfreund Circulating DNA as a possible factor in oncogenesis Science 148 1965 374 376
10. D. Koffler, V. Agnello, R. Winchester, and H.G. Kunkel The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases J. Clin. Invest. 52 1973 198 204
11. S.A. Leon, B. Shapiro, D.M. Sklaroff, and M.J. Yaros Free DNA in the serum of cancer patients and the effect of therapy Cancer Res. 37 1977 646 650
12. B. Shapiro, M. Chakrabarty, E.M. Cohn, and S.A. Leon Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease Cancer 51 1983 2116 2120
13. D. Behera, K. Gumbhir, S.K. Malik, and H.M. Dani Lung cancer and circulating DNA Ind. J. Chest Dis. Allied Sci. 28 1986 54 55
14. M. Stroun, P. Anker, J. Lyautey, C. Lederrey, and P.A. Maurice Isolation and characterization of DNA from the plasma of cancer patients Eur. J. Cancer Clin. Oncol. 23 1987 707 712
15. P. Anker, F. Lefort, V. Vasioukhin, J. Lyautey, C. Lederrey, X.Q. Chen, M. Stroun, H.E. Mulcahy, and M.J. Farthing K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer Gastroenterology 112 1997 1114 1120
16. Y.M. Lo Circulating nucleic acids in plasma and serum: An overview Ann. NY. Acad. Sci. 945 2001 1 7
17. B. Taback, and D.S. Hoon Circulating nucleic acids in plasma and serum: past, present, and future Curr. Opin. Mol. Ther. 6 2004 273 278
18. Y.K. Tong, and Y.M. Lo Diagnostic developments involving cell-free (circulating) nucleic acids Clin. Chim. Acta 363 2006 187 196
19. V.V. Vlassov, P.P. Laktionov, and E.Y. Rykova Circulating nucleic acids as a potential source for cancer biomarkers Curr. Mol. Med. 10 2010 142 165
20. S. Jahr, H. Hentze, S. Englisch, D. Hardt, F.O. Fackelmayer, R.D. Hesch, and R. Knippers DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells Cancer Res. 61 2001 1659 1665
21. F. Diehl, M. Li, D. Dressman, Y. He, D. Shen, S. Szabo, L.A. Diaz Jr., S.N. Goodman, K.A. David, H. Juhl, K.W. Kinzler, and B. Vogelstein Detection and quantification of mutations in the plasma of patients with colorectal tumors Proc. Natl. Acad. Sci. USA 102 2005 16368 16373
22. G. Brouckaert, M. Kalai, D.V. Krysko, X. Saelens, D. Vercammen, M.N. Ndlovu, G. Haegeman, K. D'Herde, and P. Vandenabeele Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production Mol. Biol. Cell 15 2004 1089 1100
23. J.J. Choi, C.F. Reich III, and D.S. Pisetsky The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells Immunology 115 2005 55 62
24. R.H. Thomlinson, and L.H. Gray The histological structure of some human lung cancers and the possible implications for radiotherapy Br. J. Cancer 9 1955 539 549
25. R.D. Leek, R.J. Landers, A.L. Harris, and C.E. Lewis Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast Br. J. Cancer 79 1999 991 995
26. N. Umetani, S. Hiramatsu, and D.S. Hoon Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation Ann. N.Y. Acad. Sci. 1075 2006 299 307
27. Y.H. Su, M. Wang, D.E. Brenner, P.A. Norton, and T.M. Block Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps Ann. N.Y. Acad. Sci. 1137 2008 197 206
28. Y. Kuang, A. Rogers, B.Y. Yeap, L. Wang, M. Makrigiorgos, K. Vetrand, S. Thiede, R.J. Distel, and P.A. Janne Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer Clin. Cancer Res. 15 2009 2630 2636
29. F. Diehl, K. Schmidt, K.H. Durkee, K.J. Moore, S.N. Goodman, A.P. Shuber, K.W. Kinzler, and B. Vogelstein Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients Gastroenterology 135 2008 489 498
30. P.B. Gahan, and R. Swaminathan Circulating nucleic acids in plasma and serum: recent developments Ann. N.Y. Acad. Sci. 1137 2008 1 6
31. N. Umetani, J. Kim, S. Hiramatsu, H.A. Reber, O.J. Hines, A.J. Bilchik, and D.S. Hoon Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats Clin. Chem. 52 2006 1062 1069
32. S. Gal, C. Fidler, Y.M. Lo, M. Taylor, C. Han, J. Moore, A.L. Harris, and J.S. Wainscoat Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR Br. J. Cancer 90 2004 1211 1215
33. C. Kirsch, S. Weickmann, B. Schmidt, and M. Fleischhacker An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids Ann. N.Y. Acad. Sci. 1137 2008 135 139
34. L. Boni, E. Cassinotti, M. Canziani, G. Dionigi, F. Rovera, and R. Dionigi Free circulating DNA as possible tumour marker in colorectal cancer Surg. Oncol. 16 Suppl. 1 2007 S29 S31
35. M. van der Vaart, and P.J. Pretorius Is the role of circulating DNA as a biomarker of cancer being prematurely overrated? Clin. Biochem. 43 2010 26 36
36. I. Muller, K. Urban, K. Pantel, and H. Schwarzenbach Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia Ann. N.Y. Acad. Sci. 1075 2006 222 229
37. I.H. Wong, Y.M. Lo, J. Zhang, C.T. Liew, M.H. Ng, N. Wong, P.B. Lai, W.Y. Lau, N.M. Hjelm, and P.J. Johnson Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients Cancer Res. 59 1999 71 73
38. T.S. Wong, D.L. Kwong, J.S. Sham, W.I. Wei, Y.L. Kwong, and A.P. Yuen Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma Clin. Cancer Res. 10 2004 2401 2406
39. M. Frattini, G. Gallino, S. Signoroni, D. Balestra, L. Lusa, L. Battaglia, G. Sozzi, L. Bertario, E. Leo, S. Pilotti, and M.A. Pierotti Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer Cancer Lett. 263 2008 170 181
40. U. Deligezer, F. Yaman, N. Erten, and N. Dalay Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients Clin. Chim. Acta 335 2003 89 94
41. J.F. Wang, and D.Q. Dai Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer World J. Gastroenterol. 13 2007 5692 5698
42. K. Fujiwara, N. Fujimoto, M. Tabata, K. Nishii, K. Matsuo, K. Hotta, T. Kozuki, M. Aoe, K. Kiura, H. Ueoka, and M. Tanimoto Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer Clin. Cancer Res. 11 2005 1219 1225
43. M. Fleischhacker, and B. Schmidt Circulating nucleic acids (CNAs) and cancer - a survey Biochim. Biophys. Acta 1775 2007 181 232
44. V.L. Wilson, X. Yin, B. Thompson, K.R. Wade, J.P. Watkins, Q. Wei, and W.R. Lee Oncogenic base substitution mutations in circulating leukocytes of normal individuals Cancer Res. 60 2000 1830 1834
45. V.L. Wilson Detecting rare mutations associated with cancer risk Am. J. Pharmacogenomics 1 2001 283 293
46. S.G. Fischer, and L.S. Lerman DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory Proc. Natl. Acad. Sci. USA 80 1983 1579 1583
47. K. Khrapko, J.S. Hanekamp, W.G. Thilly, A. Belenkii, F. Foret, and B.L. Karger Constant denaturant capillary electrophoresis (CDCE): a high resolution approach to mutational analysis Nucleic Acids Res. 22 1994 364 369
48. J. Schell, M. Wulfert, and D. Riesner Detection of point mutations by capillary electrophoresis with temporal temperature gradients Electrophoresis 20 1999 2864 2869
49. L. Zhu, H.K. Lee, B. Lin, and E.S. Yeung Spatial temperature gradient capillary electrophoresis for DNA mutation detection Electrophoresis 22 2001 3683 3687
50. M. Minarik, L. Minarikova, J. Bjorheim, and P.O. Ekstrom Cycling gradient capillary electrophoresis: a low-cost tool for high-throughput analysis of genetic variations Electrophoresis 24 2003 1716 1722
51. P.O. Ekstrom, J. Bjorheim, and W.G. Thilly Technology to accelerate pangenomic scanning for unknown point mutations in exonic sequences: cycling temperature capillary electrophoresis (CTCE) BMC Genet. 8 2007 54
52. P.O. Ekstrom, K. Khrapko, X.C. Li-Sucholeiki, I.W. Hunter, and W.G. Thilly Analysis of mutational spectra by denaturing capillary electrophoresis Nat. Protoc. 3 2008 1153 1166
53. A. Gerhardus, H. Schleberger, B. Schlegelberger, and D. Gadzicki Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review Eur. J. Hum. Genet. 15 2007 619 627
54. J. Bjorheim, M. Minarik, G. Gaudernack, and P.O. Ekstrom Evaluation of denaturing conditions in analysis of DNA variants applied to multi-capillary electrophoresis instruments J. Sep. Sci. 26 2003 1163 1168
55. M. Minarik, L. Minarikova, M. Hrabikova, P. Minarikova, P. Hrabal, and M. Zavoal Application of cycling gradient capillary electrophoresis to detection of APC, K-ras, and DCC point mutations in patients with sporadic colorectal tumors Electrophoresis 25 2004 1016 1021
56. L. Benesova, M. Pesek, B. Belsanova, P. Sekerka, and M. Minarik Denaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapy J. Sep. Sci. 33 2010 2349 2355
57. X.C. Li-Sucholeiki, and W.G. Thilly A sensitive scanning technology for low frequency nuclear point mutations in human genomic DNA Nucleic Acids Res. 28 2000 e44
58. V.L. Wilson, Q. Wei, K.R. Wade, M. Chisa, D. Bailey, C.M. Kanstrup, X. Yin, C.M. Jackson, B. Thompson, and W.R. Lee Needle-in-a-haystack detection and identification of base substitution mutations in human tissues Mutat. Res. 406 1999 79 100
59. M. Levy, L. Benesova, L. Lipska, B. Belsanova, P. Minarikova, G. Veprekova, M. Zavoral, and M. Minarik Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients Anticancer Res. 32 2012 1621 1626
60. M. Minarik, B. Belsanova, P. Minarikova, L. Lipska, L. Levy, G. Veprekova, V. Visokai, M. Zavoral, and L. Benesova Circulating free tumor DNA in patient plasma is a near-perfect marker for metastatic spread of colorectal cancer: a study on 165 patients undergoing surgical treatment Gastroenterology 140 2011 S343
61. H. Asano, S. Toyooka, M. Tokumo, K. Ichimura, K. Aoe, S. Ito, K. Tsukuda, M. Ouchida, M. Aoe, H. Katayama, A. Hiraki, K. Sugi, K. Kiura, H. Date, and N. Shimizu Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay Clin. Cancer Res. 12 2006 43 48
62. C. Salbe, C. Trevisiol, E. Ferruzzi, T. Mancuso, R. Nascimbeni, F. Di Fabio, B. Salerni, and R. Dittadi Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients Int. J. Biol. Markers 15 2000 300 307
63. C. Ausch, V. Buxhofer-Ausch, C. Oberkanins, B. Holzer, M. Minai-Pour, S. Jahn, N. Dandachi, R. Zeillinger, and G. Kriegshäuser Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization J. Mol. Diagn. 11 2009 508 513
64. M. Frattini, D. Balestra, S. Pilotti, L. Bertario, and M.A. Pierotti Tumor location and detection of k-ras mutations in stool from colorectal cancer patients J. Natl. Cancer Inst. 95 2003 72 73
65. E. Gormally, P. Vineis, G. Matullo, F. Veglia, E. Caboux, E. Le Roux, M. Peluso, S. Garte, S. Guarrera, A. Munnia, L. Airoldi, H. Autrup, C. Malaveille, A. Dunning, K. Overvad, A. Tjønneland, E. Lund, F. Clavel, F. Chapelon, H. Boeing, A. Trichopoulou, D. Palli, V. Krogh, R. Tumino, S. Panico, H.B. Bueno-de-Mesquita, P.H. Peeters, G. Pera, C. Martinez, M. Dorronsoro, A. Barricarte, C. Navarro, J.R. Quirós, G. Hallmans, N.E. Day, T.J. Key, R. Saracci, R. Kaaks, E. Riboli, and P. Hainaut TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence. A prospective study Cancer Res. 66 2006 6871 6876
66. J. Li, L. Wang, H. Mamon, M.H. Kulke, R. Berbeco, and G.M. Makrigiorgos Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing Nat. Med. 14 2008 579 584
67. I. Mancini, C. Santucci, R. Sestini, L. Simi, N. Pratesi, F. Cianchi, R. Valanzano, P. Pinzani, and C. Orlando The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer J. Mol. Diagn. 12 2010 705 711
68. P. Carotenuto, C. Roma, S. Cozzolino, F. Fenizia, A.M. Rachiglio, F. Tatangelo, A. Iannaccone, L. Baron, G. Botti, and N. Normanno Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR Int. J. Oncol. 40 2012 378 384
69. Z. Zuo, S.S. Chen, P.K. Chandra, J.M. Galbincea, M. Soape, S. Doan, B.A. Barkoh, H. Koeppen, L.J. Medeiros, and R. Luthra Application of COLD-PCR for improved detection of KRAS mutations in clinical samples Mod. Pathol. 22 2009 1023 1031
70. M. Holdhoff, K. Schmidt, F. Diehl, N. Aggrawal, P. Angenendt, K. Romans, D.L. Edelstein, M. Torbenson, K.W. Kinzler, B. Vogelstein, M.A. Choti, and L.A. Diaz Jr. Detection of tumor DNA at the margins of colorectal cancer liver metastasis Clin. Cancer Res. 17 2011 3551 3557
71. P.J. Sykes, S.H. Neoh, M.J. Brisco, E. Hughes, J. Condon, and A.A. Morley Quantitation of targets for PCR by use of limiting dilution BioTechniques 13 1992 444 449
72. R.W. Chiu, C.R. Cantor, and Y.M. Lo Non-invasive prenatal diagnosis by single molecule counting technologies Trends Genet. 25 2009 324 331
73. H.C. Fan, Y.J. Blumenfeld, Y.Y. El-Sayed, J. Chueh, and S.R. Quake Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy Am. J. Obstet. Gynecol. 200 2009 543 547
74. B.G. Zimmermann, S. Grill, W. Holzgreve, X.Y. Zhong, L.G. Jackson, and S. Hahn Digital PCR: a powerful new tool for noninvasive prenatal diagnosis? Prenat. Diagn. 28 2008 1087 1093
75. F.M. Lun, R.W. Chiu, K.C.A. Chan, L.T. Yeung, L.T. Kin, and Y.M.D. Lo Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma Clin. Chem. 54 2008 1664 1672
76. E.A. Ottesen, J.W. Hong, S.R. Quake, and J.R. Leadbetter Microfluidic digital PCR enables multigene analysis of individual environmental bacteria Science 314 2006 1464 1467
77. J. Wang, R. Ramakrishnan, Z. Tang, W. Fan, A. Kluge, A. Dowlati, R.C. Jones, and P.C. Ma Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays Clin. Chem. 56 2010 623 632
78. F. McCaughan, E. Darai-Ramqvist, A.T. Bankier, B.A. Konfortov, N. Foster, P.J. George, T.H. Rabbitts, M. Kost-Alimova, P.H. Rabbitts, and P.H. Dear Microdissection molecular copy-number counting (microMCC): unlocking cancer archives with digital PCR J. Pathol. 216 2008 307 316
79. B. Vogelstein, and K.W. Kinzler Digital PCR Proc. Natl. Acad. Sci. USA 96 1999 9236 9241
80. G. Pohl, and I. Shih Principle and applications of digital PCR Expert Rev. Mol. Diagn. 4 2004 41 47
81. S. M. Dong, G. Traverso, C. Johnson, L. Geng, R. Favis, K. Boynton, K. Hibi, S. N. Goodman, M. D'Allessio, P. Paty, S. R. Hamilton, D. Sidransky, F. Barany, B. Levin, A. Shuber, K. W. Kinzler, B. Vogelstein, J. Jen, Detecting colorectal cancer in stool with the use of multiple genetic targets, J. Natl. Cancer Inst. 93 (2001) 858-865.
82. V. Taly, D. Pekin, S. Kotsopoulos, X. Li, I. Atochin, H. Gang, D. Le Corre, L. Benhaim, J.B. Hutchison, D.R. Link, H. Blons, and P. Laurent-Puig Quantitative Detection of Circulating Tumor DNA by Droplet-Based Digital PCR, CNRS, Université Paris-Descartes, INSERM UMR-S775 2012 Université de Strasbourg France
83. F. Shen, W. Du, J.E. Kreutz, A. Fok, and R.F. Ismagilov Digital PCR on a SlipChip Lab. Chip 10 2010 2666 2672
84. D. Keller, C. Bustamante, and R.W. Keller Imaging of single uncoated DNA molecules by scanning tunneling microscopy Proc. Natl. Acad. Sci. USA 86 1989 5356 5360
85. I. Braslavsky, B. Hebert, E. Kartalov, and S.R. Quake Sequence information can be obtained from single DNA molecules Proc. Natl. Acad. Sci. USA 100 2003 3960 3964
86. H. Bayley Sequencing single molecules of DNA Curr. Opin. Chem. Biol. 10 2006 628 637
87. A. Crut, B. Geron-Landre, I. Bonnet, S. Bonneau, P. Desbiolles, and C. Escude Detection of single DNA molecules by multicolor quantum-dot end-labeling Nucleic Acids Res. 33 2005 e98
88. S. Brakmann, and S. Lobermann A further step towards single-molecule sequencing: Escherichia coli exonuclease III degrades DNA that is fluorescently labeled at each base pair Angew. Chem. Int. Ed. Engl. 41 2002 3215 3217
89. S.Y. Park, M. Gonen, H.J. Kim, F. Michor, and K. Polyak Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype J. Clin. Invest. 120 2010 636 644
90. S. Yachida, S. Jones, I. Bozic, T. Antal, R. Leary, B. Fu, M. Kamiyama, R.H. Hruban, J.R. Eshleman, M.A. Nowak, V.E. Velculescu, K.W. Kinzler, B. Vogelstein, and C.A. Iacobuzio-Donahue Distant metastasis occurs late during the genetic evolution of pancreatic cancer Nature 467 2010 1114 1117
91. B. Timmermann, M. Kerick, C. Roehr, A. Fischer, M. Isau, S.T. Boerno, A. Wunderlich, C. Barmeyer, P. Seemann, J. Koenig, M. Lappe, A.W. Kuss, M. Garshasbi, L. Bertram, K. Trappe, M. Werber, B.G. Herrmann, K. Zatloukal, H. Lehrach, and M.R. Schweiger Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis PLoS One 5 2010 e15661
92. T. Sjöblom, S. Jones, L.D. Wood, D.W. Parsons, J. Lin, T.D. Barber, D. Mandelker, R.J. Leary, J. Ptak, N. Silliman, S. Szabo, P. Buckhaults, C. Farrell, P. Meeh, S.D. Markowitz, J. Willis, D. Dawson, J.K. Willson, A.F. Gazdar, J. Hartigan, L. Wu, C. Liu, G. Parmigiani, B.H. Park, K.E. Bachman, N. Papadopoulos, B. Vogelstein, K.W. Kinzler, and V.E. Velculescu The consensus coding sequences of human breast and colorectal cancers Science 314 2006 268 274
93. A. Baudot, F.X. Real, J.M. Izarzugaza, and A. Valencia From cancer genomes to cancer models: bridging the gaps EMBO Rep. 10 2009 359 366
94. P. Vasovcak, K. Pavlikova, Z. Sedlacek, P. Skapa, M. Kouda, J. Hoch, and A. Krepelova Molecular genetic analysis of 103 sporadic colorectal tumours in Czech patients PLoS One 6 2011 e24114
95. N. Wagle, M.F. Berger, M.J. Davis, B. Blumenstiel, M. Defelice, P. Pochanard, M. Ducar, P. Van Hummelen, L.E. Macconaill, W.C. Hahn, M. Meyerson, S.B. Gabriel, and L.A. Garraway High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing Cancer Discov. 2 2012 82 93
96. T. Forshew, M. Murtaza, C. Parkinson, D. Gale, D.W. Tsui, F. Kaper, S.J. Dawson, A.M. Piskorz, M. Jimenez-Linan, D. Bentley, J. Hadfield, A.P. May, C. Caldas, J.D. Brenton, and N. Rosenfeld Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA Sci. Transl. Med. 4 2012 136ra68